Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Quantitative Assessment of Swallowing Dysfunction in Patients with Spinal and Bulbar Muscular Atrophy.

Hashizume A, Banno H, Katsuno M, Hijikata Y, Yamada S, Inagaki T, Suzuki K, Sobue G.

Intern Med. 2017 Dec 1;56(23):3159-3165. doi: 10.2169/internalmedicine.8799-16. Epub 2017 Oct 11.

2.

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases.

Takeuchi T, Nagai Y.

Brain Sci. 2017 Oct 11;7(10). pii: E128. doi: 10.3390/brainsci7100128. Review.

3.

Swallowing markers in spinal and bulbar muscular atrophy.

Banno H, Katsuno M, Suzuki K, Tanaka S, Suga N, Hashizume A, Mano T, Araki A, Watanabe H, Fujimoto Y, Yamamoto M, Sobue G.

Ann Clin Transl Neurol. 2017 May 24;4(8):534-543. doi: 10.1002/acn3.425. eCollection 2017 Aug.

4.

Identification of neuron selective androgen receptor inhibitors.

Otto-Duessel M, Tew BY, Vonderfecht S, Moore R, Jones JO.

World J Biol Chem. 2017 May 26;8(2):138-150. doi: 10.4331/wjbc.v8.i2.138.

5.

The Use of Korean Medicine to Treat Patients with Spinobulbar Muscular Atrophy, Kennedy's Disease - A Case Study.

Lee S, Cha E, Lee J, Lee J, Song I, Kim S.

J Pharmacopuncture. 2017 Mar;20(1):57-60. doi: 10.3831/KPI.2017.20.009.

6.

Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes.

Milioto C, Malena A, Maino E, Polanco MJ, Marchioretti C, Borgia D, Pereira MG, Blaauw B, Lieberman AP, Venturini R, Plebani M, Sambataro F, Vergani L, Pegoraro E, SorarĂ¹ G, Pennuto M.

Sci Rep. 2017 Jan 24;7:41046. doi: 10.1038/srep41046.

7.

Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients.

Borgia D, Malena A, Spinazzi M, Desbats MA, Salviati L, Russell AP, Miotto G, Tosatto L, Pegoraro E, SorarĂ¹ G, Pennuto M, Vergani L.

Hum Mol Genet. 2017 Mar 15;26(6):1087-1103. doi: 10.1093/hmg/ddx019.

8.

Trinucleotide repeats and protein folding and disease: the perspective from studies with the androgen receptor.

Orafidiya FA, McEwan IJ.

Future Sci OA. 2015 Sep 1;1(2):FSO47. doi: 10.4155/fso.15.47. eCollection 2015 Sep. Review.

9.

Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy.

Yamada S, Hashizume A, Hijikata Y, Inagaki T, Suzuki K, Kondo N, Kawai K, Noda S, Nakanishi H, Banno H, Hirakawa A, Koike H, Halievski K, Jordan CL, Katsuno M, Sobue G.

PLoS One. 2016 Dec 22;11(12):e0168846. doi: 10.1371/journal.pone.0168846. eCollection 2016.

10.

Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.

Rocchi A, Milioto C, Parodi S, Armirotti A, Borgia D, Pellegrini M, Urciuolo A, Molon S, Morbidoni V, Marabita M, Romanello V, Gatto P, Blaauw B, Bonaldo P, Sambataro F, Robins DM, Lieberman AP, SorarĂ¹ G, Vergani L, Sandri M, Pennuto M.

Acta Neuropathol. 2016 Jul;132(1):127-44. doi: 10.1007/s00401-016-1550-4. Epub 2016 Mar 12.

11.

Preventing the Androgen Receptor N/C Interaction Delays Disease Onset in a Mouse Model of SBMA.

Zboray L, Pluciennik A, Curtis D, Liu Y, Berman-Booty LD, Orr C, Kesler CT, Berger T, Gioeli D, Paschal BM, Merry DE.

Cell Rep. 2015 Dec 15;13(10):2312-23. doi: 10.1016/j.celrep.2015.11.019. Epub 2015 Dec 7.

12.

Spinal and Bulbar Muscular Atrophy Overview.

Fischbeck KH.

J Mol Neurosci. 2016 Mar;58(3):317-20. doi: 10.1007/s12031-015-0674-7. Epub 2015 Nov 7. Review.

13.

Spinal and Bulbar Muscular Atrophy.

Grunseich C, Fischbeck KH.

Neurol Clin. 2015 Nov;33(4):847-54. doi: 10.1016/j.ncl.2015.07.002. Epub 2015 Sep 8. Review.

14.

Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy.

Todd TW, Kokubu H, Miranda HC, Cortes CJ, La Spada AR, Lim J.

Elife. 2015 Aug 26;4:e08493. doi: 10.7554/eLife.08493.

15.

A randomized controlled trial of exercise in spinal and bulbar muscular atrophy.

Shrader JA, Kats I, Kokkinis A, Zampieri C, Levy E, Joe GO, Woolstenhulme JG, Drinkard BE, Smith MR, Ching W, Ghosh L, Fox D, Auh S, Schindler AB, Fischbeck KH, Grunseich C.

Ann Clin Transl Neurol. 2015 Jul;2(7):739-47. doi: 10.1002/acn3.208. Epub 2015 May 7.

16.

Proceedings of the fourth international conference on central hypoventilation.

Trang H, Brunet JF, Rohrer H, Gallego J, Amiel J, Bachetti T, Fischbeck KH, Similowski T, Straus C, Ceccherini I, Weese-Mayer DE, Frerick M, Bieganowska K, Middleton L, Morandi F, Ottonello G; European Central Hypoventilation Syndrome Consortium.

Orphanet J Rare Dis. 2014 Dec 5;9:194. doi: 10.1186/s13023-014-0194-5. Review.

17.

A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study.

Hashizume A, Katsuno M, Suzuki K, Banno H, Suga N, Mano T, Araki A, Hijikata Y, Grunseich C, Kokkinis A, Hirakawa A, Watanabe H, Yamamoto M, Fischbeck KH, Sobue G.

Neuromuscul Disord. 2015 Jul;25(7):554-62. doi: 10.1016/j.nmd.2015.03.008. Epub 2015 Mar 20.

18.

Head and Arm Tremor in X-linked Spinal and Bulbar Muscular Atrophy.

Aicua I, Verhagen O, Arenaza N, Cubo E.

Tremor Other Hyperkinet Mov (N Y). 2014 Oct 8;4:265. doi: 10.7916/D8959FVJ. eCollection 2014.

19.

Reliability of the adult myopathy assessment tool in individuals with myositis.

Harris-Love MO, Joe G, Davenport TE, Koziol D, Abbett Rose K, Shrader JA, Vasconcelos OM, McElroy B, Dalakas MC.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):563-70. doi: 10.1002/acr.22473.

20.

Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy.

Giorgetti E, Rusmini P, Crippa V, Cristofani R, Boncoraglio A, Cicardi ME, Galbiati M, Poletti A.

Hum Mol Genet. 2015 Jan 1;24(1):64-75. doi: 10.1093/hmg/ddu419. Epub 2014 Aug 13.

Supplemental Content

Support Center